SCHEMBL688286

SCHEMBL688286

CCCOc1cccc(Cl)c1Cn1cc(C)c(O)c(NC(=O)N[C@@H](CC(=O)O)c2ccc(C)cc2)c1=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.39
CTSA P10619 10/20 0.38
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
P2RX3 P56373 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK1 P28482 1/20 0.33
POLB P06746 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687715 0.94 CTSA (0.39) SMN1; SMN2CTSAALDH1A1KDM4EMAPT
SCHEMBL688273 0.91 CTSA (0.38) CTSAALDH1A1KDM4EMAPK1POLB
SCHEMBL687499 0.91 CTSA (0.45) CTSAPOLB
SCHEMBL687851 0.90 CTSA (0.38) SMN1; SMN2CTSAALDH1A1KDM4ENPC1
SCHEMBL687688 0.90 SMN1; SMN2 (0.37) SMN1; SMN2CTSAALDH1A1KDM4ELMNA
SCHEMBL688046 0.90 CTSA (0.42) SMN1; SMN2CTSAALDH1A1KDM4ECYP3A4
SCHEMBL688507 0.88 SMN1; SMN2 (0.38) SMN1; SMN2CTSAALDH1A1KDM4ELMNA
SCHEMBL688146 0.88 CTSA (0.41) CTSAALDH1A1KDM4ECYP3A4CYP2C9
SCHEMBL688429 0.88 GUCY1B2 (0.41) SMN1; SMN2CTSAALDH1A1KDM4EMAPK1
SCHEMBL13120932 0.87 MAPT (0.38) SMN1; SMN2ALDH1A1KDM4EMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed